NCT00281320View on ClinicalTrials.gov

Study of Asenapine in Elderly Subjects With Psychosis (A7501021)(P05717)

PHASE3CompletedINTERVENTIONAL
Enrollment

122

Participants

Timeline

Start Date

February 28, 2006

Primary Completion Date

December 31, 2008

Study Completion Date

December 31, 2008

Conditions
Psychosis
Interventions
DRUG

Asenapine

Asenapine 2 mg twice daily (BID) on Days 1 and 2, 5 mg BID on Days 3 and 4, followed by 10 mg BID on Day 5 through the end of the trial (Week 6); or Asenapine 5 mg BID on Days 1 to 4 followed by 10 mg BID on Day 5 through the end of the trial (Week 6).

All Listed Sponsors
lead

Organon and Co

INDUSTRY

NCT00281320 - Study of Asenapine in Elderly Subjects With Psychosis (A7501021)(P05717) | Biotech Hunter | Biotech Hunter